MoUJul 31, 2026, 09:56 AM
Instinct Bio Partners INVITRX for US Expansion, Indonesia Regenerative Med
AI Summary
Instinct Bio announced a strategic collaboration with INVITRX Therapeutics, Inc. through a Memorandum of Agreement. This partnership aims to expand Instinct Bio's GENRÊVER cosmetic products into the U.S. market and advance regenerative medicine initiatives in Indonesia. The collaboration leverages an existing six-year relationship, combining Japanese product innovation with U.S. GMP manufacturing capabilities, with definitive commercial agreements to be negotiated.
Key Highlights
- Instinct Bio announced a strategic collaboration with INVITRX Therapeutics, Inc. via a Memorandum of Agreement (MOA).
- The collaboration aims to expand Instinct Bio's GENRÊVER cosmetic products into the U.S. market.
- It also includes initiatives to advance regenerative medicine in Indonesia, with INVITRX supplying concentrated exosomes and conditioned media.
- The partnership builds on a proven six-year commercial relationship between Instinct Bio and INVITRX.
- Instinct Bio's subsidiaries, Instinct Brothers Co., Ltd. and Artisans Production Co., Ltd., are involved.
- INVITRX is expected to manufacture GENRÊVER products at its U.S. GMP manufacturing facility.
- The parties intend to negotiate definitive commercial agreements for manufacturing, supply, and commercialization.
Price Impact
More from BIOT